CAPR
Capricor Therapeutics Inc
9.50$
+10.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -31 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.8 | -12 | -1.3 | -12 | -12 | -15 | -6.4 | -20 | -20 | -24 | -29 | -31 | -104 | |
| 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 247 | 1,003 | 0.5 | 296 | 1,547 | |
| 1.7 | 1.9 | 3.3 | 2.2 | 2.1 | 2.3 | 5.7 | 3.6 | 7,369 | -3,394 | 5.9 | 9,578 | 13,559 | |
| -4.4 | -13 | 4.9 | -3.8 | -1.2 | -10 | 12 | 1.7 | 0.0 | -1.2 | -2.0 | 2.0 | -1.2 | |
| 0.6 | 0.7 | 0.7 | 0.1 | 0.1 | 0.7 | 1.1 | 1.4 | 4.0 | 5.1 | 11 | 5.9 | 26 | |
| 7.7 | -5.9 | -9.5 | 15 | 2.0 | -123 | 24 | 15 | 16 | 43 | -155 | -49 | -144 | |
| 0.2 | 23 | 2.3 | 2.1 | 67 | 81 | 0.1 | 0.0 | 0.0 | 249 | 1.5 | -4.2 | 246 | |
| -0.9 | 5.7 | -8.5 | 4.5 | 58 | -57 | 18 | -5.6 | -3.7 | 268 | -182 | -84 | -2.3 | |
| -9.4 | -12 | -1.9 | -12 | -12 | -16 | -7.6 | -22 | -24 | -29 | -40 | -37 | -130 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.